Presence of kynurenic acid and kynurenine aminotransferases in the inner retina

Kynurenine aminotransferases (KATs I and II) are pivotal to the synthesis of kynurenic acid (KYNA), the only known endogenous glutamate receptor antagonist and neuroprotectant. This study is the first to identify KYNA in the rat retina and to examine immunohistochemically the distribution of KAT isoforms. As determined by HPLC, KYNA concentration in the retina was 99.9 ± 24.6 pmol/g wet wt. Immunohisto- chemical experiments showed that both KATs were present in the retina. KAT I was preferentially localised on Müller cell endfeet while KAT II was expressed in cells within the ganglion cell layer. In conclusion, KYNA is present and synthesised in the inner retina. This may suggest a modulatory role in glutamate-mediated retinal neurotransmission.

[1]  W. Turski,et al.  Evidence for Intraocular Synthesis of Kynurenic Acid, a Putative Endogenous Neuroprotectant , 2001, Ophthalmic Research.

[2]  T. Stone,et al.  Endogenous neurotoxins from tryptophan. , 2001, Toxicon : official journal of the International Society on Toxinology.

[3]  L. Vécsei,et al.  Effects of in vivo sodium azide administration on the immunohistochemical localization of kynurenine aminotransferase in the rat brain , 1999, Neuroscience.

[4]  A. Chiarugi,et al.  The kynurenine metabolic pathway in the eye: studies on 3‐hydroxykynurenine, a putative cataractogenic compound , 1999, FEBS letters.

[5]  F. Moroni,et al.  Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia. , 1999, Advances in experimental medicine and biology.

[6]  V. Kapoor,et al.  Immuno‐localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord , 1997, Neuroreport.

[7]  R. Schwarcz,et al.  Characterization of rat brain kynurenine aminotransferases I and II , 1997, Journal of neuroscience research.

[8]  M. Kreutz,et al.  Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats. , 1996, Investigative ophthalmology & visual science.

[9]  P. Malherbe,et al.  Cloning and Functional Expression of a Soluble Form of Kynurenine/α -Aminoadipate Aminotransferase from Rat Kidney * , 1995, The Journal of Biological Chemistry.

[10]  R. Schwarcz,et al.  Immunocytochemical localization of kynurenine aminotransferase in the rat striatum: A light and electron microscopic study , 1992, The Journal of comparative neurology.

[11]  R. Schwarcz,et al.  Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus , 1992, The Journal of comparative neurology.

[12]  M. Beal,et al.  Neuroprotective Effects of L-Kynurenine on Hypoxia—Ischemia and NMDA Lesions in Neonatal Rats , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  R. Schwarcz,et al.  Kynurenic Acid: A Potential Pathogen in Brain Disorders a , 1992, Annals of the New York Academy of Sciences.

[14]  R. Schwarcz,et al.  Two kynurenine aminotransferases in human brain , 1991, Brain Research.

[15]  R. Schwarcz,et al.  Purification and characterization of kynurenine-pyruvate aminotransferase from rat kidney and brain , 1990, Brain Research.

[16]  T. Guilarte,et al.  Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line , 1989, Brain Research.

[17]  R. Schwarcz,et al.  High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  R. Schwarcz,et al.  Rat Brain Slices Produce and Liberate Kynurenic Acid upon Exposure to l‐Kynurenine , 1989, Journal of neurochemistry.

[19]  G. Lynch,et al.  A Glycine Site Associated with N‐Methyl‐d‐Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists , 1989, Journal of neurochemistry.

[20]  P. Andiné,et al.  The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection , 1988, Neuroscience Letters.

[21]  G. Lombardi,et al.  Presence of Kynurenic Acid in the Mammalian Brain , 1988, Journal of neurochemistry.

[22]  R. Schwarcz,et al.  Identification and quantification of kynurenic acid in human brain tissue , 1988, Brain Research.

[23]  K. Shibata,et al.  Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography. , 1988, Journal of chromatography.

[24]  R. Schwarcz,et al.  Quinolinate. A selective neurotoxin in embryonic and posthatching chicken retinas. , 1985, Investigative ophthalmology & visual science.

[25]  R. Schwarcz,et al.  Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid , 1984, Neuroscience Letters.

[26]  T. Stone,et al.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid , 1982, Brain Research.